Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia

Fam Cancer. 2017 Jul;16(3):441-446. doi: 10.1007/s10689-017-9968-y.

Abstract

Fanconi anaemia (FA) is a genotypically and phenotypically heterogeneous genetic condition, characterized cytogenetically by chromosomal instability and breakage secondary to impaired DNA repair mechanisms. Affected individuals typically manifest growth restriction and congenital physical abnormalities and most progress to hematological disease including bone marrow aplasia. A rare genetic subtype of FA (FA-D1) is caused by biallelic mutations in the BRCA2 gene. Affected individuals manifest severe congenital anomalies and significant pigmentary changes and are additionally at risk for early onset leukemia and certain solid organ malignancies, including Wilms tumors and brain tumors. Parents of affected individuals are obligate carriers for heterozygous BRCA2 mutations and are thus potentially at risk for adult onset cancers which fall within the hereditary breast and ovarian cancer spectrum. We present two cases of black South African patients with FA diagnosed with biallelic BRCA2 mutations and discuss the phenotypic consequences and implications for them and their families. Recognition of this severe end of the phenotypic spectrum of FA is critical in allowing for confirmation of the diagnosis as well as cascade screening and appropriate care of family members.

Keywords: BRCA2 mutations; Black South African patients; Cascade screening; Fanconi anaemia; Hereditary breast and ovarian cancer syndrome.

Publication types

  • Case Reports

MeSH terms

  • BRCA2 Protein / genetics*
  • Child, Preschool
  • Fanconi Anemia / genetics*
  • Female
  • Genes, BRCA2
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mutation
  • Pedigree
  • South Africa

Substances

  • BRCA2 Protein
  • BRCA2 protein, human